Tools

LEADER 03452nam 2200553 i 4500

001 on1425138716;

003 OCoLC;

005 20240306113903.0;

006 m o d f ;

007 cr b|||||a||||;

008 240306s2024 dcu ob f000 0 eng c;

024 8 a| 52-000q| (GPO jacket number);

035 a| (Sirsi) o1425138716;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:118-4;

088 a| Serial no. 118-4 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Challenges and opportunities to investigating the origins of pandemics and other biological events :b| hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, February 1, 2023.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2024.;

300 a| 1 online resource (vi, 149 pages);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "Serial no. 118-4.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Karen L. Howard, Ph.D., Acting Chief Scientist and Director, Science, Technology Assessment, and Analytics, Government Accountability Office; Tom Inglesby, M.D., Director, Center for Health Security, Johns Hopkins Bloomberg School of Public Health; Asha M. George, D.P.H., Executive Director, Bipartisan Commission on Biodefense; Gerald W. Parker, D.V.M., Ph.D., Associate Dean for Global One Health, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University; Michael J. Imperiale, Ph.D., Arthur F. Thurnau Professor, Department of Microbiology and Immunology, University of Michigan.;

518 a| Date of hearing: 2023-02-01.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed March 6, 2024).;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

610 20 a| Zhongguo ke xue yuan.b| Wuhan bing du yan jiu suo.=| ^A1416157;

650 0 a| COVID-19 (Disease)x| Etiology.=| ^A1407776;

650 0 a| COVID-19 Pandemic, 2020-2023z| United States.=| ^A1418885;

650 0 a| Medical laboratoriesx| Safety measures.=| ^A606285;

650 0 a| Communicable diseasesz| United Statesx| Prevention.=| ^A824;

650 0 a| National securityz| United States.=| ^A273467;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.t| Challenges and opportunities to investigating the origins of pandemics and other biological eventsw| (OCoLC)1425137769;

856 40 u| https://purl.fdlp.gov/GPO/gpo2231607| 0;

922 a| BIBCONEWb| 20240306;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6339880;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6339880-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 4/15/2024x| EDOCUMENTz| JERESOURCE;

Challenges and opportunities to investigating the origins of pandemics and other biological events : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, February 1, 2023.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2024.
Description	1 online resource (vi, 149 pages)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo223160
Subjects	Zhongguo ke xue yuan. Wuhan bing du yan jiu suo. COVID-19 (Disease)--Etiology. COVID-19 Pandemic, 2020-2023--United States. Medical laboratories--Safety measures. Communicable diseases--United States. --Prevention. National security--United States.

General note	"Serial no. 118-4."
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Karen L. Howard, Ph.D., Acting Chief Scientist and Director, Science, Technology Assessment, and Analytics, Government Accountability Office; Tom Inglesby, M.D., Director, Center for Health Security, Johns Hopkins Bloomberg School of Public Health; Asha M. George, D.P.H., Executive Director, Bipartisan Commission on Biodefense; Gerald W. Parker, D.V.M., Ph.D., Associate Dean for Global One Health, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University; Michael J. Imperiale, Ph.D., Arthur F. Thurnau Professor, Department of Microbiology and Immunology, University of Michigan.
Date/time/place of a event note	Date of hearing: 2023-02-01.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed March 6, 2024).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Challenges and opportunities to investigating the origins of pandemics and other biological events
Genre/form	Legislative hearings.
Standard identifier#	52-000 (GPO jacket number)
Technical rpt number	Serial no. 118-4 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:118-4

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Challenges and opportunities to investigating the origins of pandemics and other biological events : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, February 1, 2023.

Click here for more information about this title

Availability